Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06165016 · ClinicalTrials.gov registry record · NA
Far Red Light to Improve Functioning in PAD
A NA study of Aging and Peripheral Artery Disease, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 2
- Study locations
NCT06165016 is a NA study of Aging and Peripheral Artery Disease that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 32 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06165016, a NA study of Aging and Peripheral Artery Disease, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 2
- Study locations
Study Summary
The LIGHT PAD Trial is a Phase II multi-centered randomized clinical trial to collect preliminary data to test whether daily far red light treatment of the lower extremities in people with PAD improves six-minute walk distance, lower extremity perfusion, and ischemia-related damage in gastrocnemius muscle at four-month follow-up, compared to a sham control. Participants will complete 10 minutes of twice daily home treatment with either far red light or a sham light for four months.
Conditions Studied
Interventions
- DEVICE Far red light therapy
- DEVICE Sham light therapy
Study Locations (2)
Alabama
- University of Alabama at Birmingham - Birmingham
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-02-14 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06165016
The ClinicalTrials.gov registry entry for NCT06165016 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Far red light therapy is the first listed.
NCT06165016 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Illinois.
Frequently Asked Questions
What is clinical trial NCT06165016 about?
NCT06165016 is a clinical study titled "Far Red Light to Improve Functioning in PAD". The LIGHT PAD Trial is a Phase II multi-centered randomized clinical trial to collect preliminary data to test whether daily far red light treatment of the lower extremities in people with PAD improves six-minute walk distance, lower extremity perfusion, and ischemia-related damage in gastrocnemius ...
What is the current status of trial NCT06165016?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2024-02-14. Estimated completion is 2027-06-01.
What conditions does trial NCT06165016 study?
This clinical trial studies the following conditions: Aging, Peripheral Artery Disease, Peripheral Vascular Disease, Walking, Difficulty.
What interventions are being tested in trial NCT06165016?
The interventions under investigation include: Far red light therapy (DEVICE), Sham light therapy (DEVICE).
Who is sponsoring clinical trial NCT06165016?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06165016 being conducted?
This trial has 2 study locations across Alabama, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.